Public Health Agency of Canada
Symbol of the Government of Canada

Share this page

Canadian Guidelines on Sexually Transmitted Infections

[Previous page] [Table of Contents] [Next page]

In 2013, revisions were made to the Gonococcal Infections chapter in response to emerging antimicrobial resistance. As such, this chapter also requires updates. A Supplementary Statement has been developed to highlight key changes key changes to screening, management and follow-up of sexually transmitted infections (STI) in cases of suspected or confirmed sexual abuse until such time as until such time as updated guidance is available. This Supplementary Statement should be used in conjunction with the 2010 chapter to ensure that the most current recommendations are being implemented in your practice.

Supplementary Statement

Section 6 - Specific Populations

Sexual Abuse in Peripubertal and Prepubertal Children


Canadian Law regarding Age of Consent to Sexual Activity (at the time of publication)

Canadian law is fairly nuanced in respect to defining the points at which sexual activities involving persons under the age of 18 become criminal offences.Footnote 1 Depending on the circumstances, any form of touching for a sexual purpose can constitute an offence. Consent is the key factor in determining whether any form of sexual activity is a criminal offence. The law recognizes some minors as having the ability to consent, in some situations. Generally speaking, persons over 14 are recognized as being able to give consent to participate in sexual activities, unless the activities are taking place in a relationship where one participant has some authority over or is in a position of trust in relation to the other person, where there is dependency, or where there is exploitation of one participant by the other. The Criminal Code provides a “close in age” exception: a 12 or 13 year old can consent to engage in sexual activity with another person who is less than two years older and with whom there is no relationship of trust, authority, dependency, or exploitation. Children under 12 do not have the legal capacity to consent to any form of sexual activity.


The definition of sexual abuse varies, but involves all sexual acts that the child cannot comprehend, for which the child is not developmentally prepared and/or cannot give consent to, and/or that violates the law.Footnote 2 Activities may range from fondling to penetration. For the purpose of these guidelines, as is relevant to the potential transmission of sexually transmitted infections (STIs), the definition will include complete or partial penetration by a penis of the mouth, anus and/or vagina, although it is noted that contact of the mouth with the external genitalia or anus could potentially transmit herpes simplex virus (HSV) infections.

In addition, for the purpose of these guidelines, peripubertal refers to individuals aged 11–13 and prepubertal to individuals less than 11 years of age.


It is difficult to accurately estimate the prevalence of sexual abuse due to underreporting. The reported prevalence varies from study to study, depending on a number of factors. This form of abuse affects children of all ages, socioeconomic classes and geographic locations.Footnote 3 Some studies estimate that approximately 1% of children experience some form of sexual abuse each year, resulting in sexual victimization of 12–25% of girls and 8–10% of boys by age 18.Footnote 4 The perpetrator may be a member of a child’s family or a complete stranger, but in either case the abuser is often an adult male (adolescents may be the perpetrators in as many as 20% of all cases). Boys may be abused as often as girls, but they are less likely to report the abuse.

The Canadian Incidence Study of Reported Child Abuse and NeglectFootnote 5 estimated that 135,573 child maltreatment investigations were carried out in Canada in 1998, an annual incidence rate of 21.52 investigations per 1,000 children. Ten percent (15,614 or 2.48 investigations per 1,000 children) of these investigations involved sexual abuse as the primary reason for investigation.

Of these, an estimated 2,742 child investigations involved allegations of oral, vaginal or anal sexual activities. Non-parental figures were most often investigated in sexual abuse cases, with non-parental relatives representing 28%, biological fathers 15% and stepfathers 9% of all cases. Seven percent of sexual abuse investigations involved mothers as alleged perpetrators (5% biological mothers and 2% stepmothers). Sixty-eight percent (~9,813 cases) involved female children, with adolescent females aged 12–15 accounting for 21% of investigations and girls 4–7 years accounting for 23%.

Multiple factors affect the risk of transmission of infection with sexual abuse, including the following:Footnote 6Footnote 9

  • Prevalence of STIs within the local population.
  • Type of sexual activity: the risk of STI transmission with penile-rectal penetration is greater than penile-vaginal penetration, which is greater than penile-oral penetration etc.
  • Degree of trauma: injuries to the genital tract are more common in children.
  • Sexual maturity of the child: altered susceptibility to STIs due to maturational differences in the genital tract.
  • Lack of use of barrier contraception.
  • Multiple episodes of abuse.

Prevention and Control

Children should be screened throughout childhood, during routine visits to health care providers’ offices, for evidence of sexual abuse. Children who may be at higher risk include those with developmental, behavioural and medical problems.Footnote 10,Footnote 11 Health care providers should also be aware that recognizing and reporting child sexual abuse is the most effective means of preventing further abuse, reactive abuse and pedophilia.Footnote 12Footnote 15


Sexually abused children may present in many ways. They may present alone or with their parents for evaluation of alleged sexual abuse. They may present at a health care provider’s office with an unrelated complaint and then disclose abuse. The health care provider may even suspect abuse during a routine visit, highlighting the need for vigilance, because abuse may present in ways that may be so non-specific that the problem may not be considered.Footnote 16Footnote 18 Rectal or genital bleeding, the presence of STIs and developmentally unusual sexual behaviour are some of the more specific signs of sexual abuse.Footnote 19

Victims of sexual assault may be reluctant to disclose that they have been sexually assaulted for a variety of reasons, including being coerced into secrecy, fear of not being believed or fear of retribution. In some instances, children may not recognize that abuse has taken place.

Assessment and follow-up of children who are victims of sexual abuse should be carried out with great sensitivity and ideal ly with the direct involvement of experienced teams or services (see Appendix G). When direct referral cannot be made (e.g., in remote areas), every effort should be made to consult with the nearest referral centre.

Health care providers who suspect the occurrence or possibility of sexual abuse should inform the parents/guardians in a calm, non-accusatory manner.Footnote 2 Health care providers need to be aware of local reporting requirements (see Reporting and Partner Notification, below).

The health care provider’s role is not to conduct a legal interview or obtain details of the abuse from the child, but rather to do the following:Footnote 20

  1. Take a pertinent medical history.
  2. Ensure the physical and emotional well-being of the patient.
  3. Treat or prevent illness or injury.
  4. Accurately record spontaneous disclosure or volunteered information.
  5. Obtain and document physical findings consistent with abuse or suspicions of abuse.
  6. Inform the child and caregivers about the medical outcome of the investigation.
  7. Assist child protection and law enforcement agencies in their investigation.

When a health care provider suspects abuse, it is essential he/she take a pertinent medical history to satisfy the medical needs of the child and generate adequate information to assist child protection agencies.

When direct referral to specialist referral centre is not possible (e.g., in remote areas), several methods may be used when asking young children about abuse.Footnote 21 The child may also spontaneously provide information. If possible, the child should be interviewed alone, although the presence of a non-threatening caregiver may be appropriate. In addition, the parents/guardians may provide a history of behavioural changes that may be relevant to the situation.

Physical exam

The following information is provided as a guide and may be useful when screening for the possibility of sexual abuse. A full evaluation should ideally be performed by a clinician experienced in this area.

Injuries requiring immediate attention should take precedence over any other examination. The physical examination should be explained to the child before it is performed and should not result in additional emotional trauma.

A complete pediatric examination should be performed, with special attention paid to the growth parameters and sexual development of the child using Tanner staging (see Appendix H). Injuries and other evidence of abuse should be documented, including bruising, swelling and areas of tenderness. If the abuse has occurred within 72 hours, or if there is bleeding or acute injury, the examination should be performed immediately so that forensic specimens can be collected.Footnote 2 After 72 hours has passed and when no acute injuries are evident, then the evaluation should be performed when convenient for the child and investigative team.

Careful examination of all areas involved in sexual activity should be performed and notes made of any abnormalities. Examination of the genital and rectal areas may be aided by instruments that illuminate and/or magnify the area. In both sexes, the anus should be examined, and in females the hymenal opening should be examined. Digital and speculum examination is not usually necessary and should not be performed in prepubertal children.

Specimen Collection and Laboratory Diagnosis

For prepubertal children, the decision to perform testing should be done on an individual basis. The following situations put the child at higher risk for STIs and are indications for testing:Footnote 22

  • The child has symptoms or signs of an STI (e.g., vaginal discharge or pain, genital itching or odour, urinary symptoms, genital ulcers or lesions).
  • The suspected assailant is known to have an STI or to be at risk for an STI.
  • Another child or adult in the household is known to have an STI.
  • The prevalence of STIs in the community is high.
  • There is evidence of genital, oral or anal penetration.

If testing is warranted, an experienced clinician (ideally one involved with a referral centre) should be consulted; the testing procedures described below are intended as a guide and for information only.

Minimal investigation should include testing for Neisseria gonorrhoeae and Chlamydia trachomatis, and if genital ulcers are present, for herpes simplex virus and syphilis. The genital organs of female infants, children and adolescents vary significantly from those of adults, influencing the microbiological flora of the genital tract and sampling sites for screening. Sampling sites need to be specific for the sexual maturity of the young person. Speculum examinations should not be performed on prepubertal children.

The health care provider may elect to use several techniques, including the use of small swabs (such as urethral or ear, nose and throat swabs) moistened with sterile saline for transhymenal vaginal sampling. Placing the child in the prone knee-chest position allows cultures to be taken without touching the hymen and causing pain and without the child being alarmed by the sight of the swab.Footnote 23 Vulvar or vaginal washings are also suitable (see Table 1).

All specimens for forensic evidence should be collected by professionals experienced in these procedures and should follow established regional/local protocols (see Appendix F).

It should be noted that most forensic kits do not contain tests for STIs or blood-borne pathogens. They are useful in the identification of semen or other body fluids, forensic DNA analysis, microscopic hair examination, textile damage assessment and examinations involving fibres and other types of trace evidence. These, in turn, may be used to establish that some form of association occurred between the victim and the accused, that sexual contact occurred and/or that the assault was violent or forceful, thereby indicating lack of consent. All isolates and specimens should be retained in case additional or repeated testing is required.

Table 1. Initial visit: prepubertal children
Specimen type by gender Condition or organism to be detected
Table 1 - Footnote *
A recently published study evaluated the use of NAAT from urine and genital specimens and showed equivalence. When compared with culture, the use of NAAT testing resulted in a 33% increase in children with a positive diagnosis for both gonorrhea and Chlamydia.Footnote 24
Table 1 - Footnote **
Vaginal specimens can be taken without a speculum in a relaxed child as long as the hymenal ring is not touched. A small swab, (e.g., urethral swab) is preferred. Speculum examination is only rarely required, and in prepubertal females requires consultation with a specialist or may require a general anesthetic.
Table 1 - Footnote
Vaginal washes are performed by instilling 1.5–2 mL of sterile, preservative-free normal saline at room temperature into the vagina via a modification of the method described by Pokorny and Stormer.Footnote 25,Footnote 26 The tubing from a 25 mm butterfly needle, with the needle and butterfly wings removed, is inserted into the distal end of a No. 8 bladder catheter. This assembly is then attached to a 3 mL syringe by the end of the butterfly tubing. This system allows for aspiration of the vaginal contents without the end of the butterfly tube becoming occluded by the vaginal walls. The normal saline and vaginal discharge fluid are then aspirated from the vagina.
Table 1 - Footnote
Baseline screening for syphilis should be considered in areas with high prevalence or regional outbreaks of syphilis, foreign-born children, parents/family members/perpetrators diagnosed with syphilis and children diagnosed with another STI.Footnote 27
herpes simplex virus
hepatitis B surface antibody
hepatitis C virus
Hepatitis B surface antigen 2
Boys and GirlsTable 1 - Footnote *
  • First-catch urine (10–20 mL) after not voiding for 2 hours
  • A molecular diagnostic test, preferably a NAATTable 1 - Footnote *, should be collected for gonorrhea and chlamydia. This test is generally more sensitive than genital culture and may be acceptable for medico-legal purposes if confirmed by a second set of primers or, in some cases, a second test sent to another laboratory
    Postexposure NAAT testing can be taken at the time of presentation, without needing to wait for 48 hours after exposure; this is based on expert opinion, which assumes that NAATs are able to detect inoculum (DNA or RNA).
GirlsTable 1 - Footnote *
Vagina, vestibule or discharge (if present)
  • 1 urethral swab, premoistened with sterile water (to minimize discomfort)Table 1 - Footnote **
  • Vaginal washTable 1 - Footnote technique preferred to multiple vaginal swabs if NAAT used for Chlamydia trachomatis and Neisseria gonorrhoeae
  • Gram stain, if available, for abnormal bacterial flora, bacterial vaginosis, candidiasis, gonorrhea should be taken
  • Molecular diagnostic tests, especially NAATsTable 1 - Footnote *, are more sensitive than culture for C. trachomatis and N. gonorrhoeae
  • Cultures have been the preferred method for medico-legal purposes, but NAATs may be acceptable if positive results are confirmed by a second set of primers or, in some cases, a second test sent to another laboratory
  • If available, both tests (culture and NAAT) should be taken
  • If available, wet mount and/or culture for T vaginalis should be taken
    Since culture tests collected <48 hours after exposure may be falsely negative, they should be repeated 1–2 weeks after exposure if prophylaxis is not offered; a postexposure NAAT can be taken at the time of presentation without waiting for 48 hours; this is based on expert opinion, which assumes that NAATs are able to detect inoculum (DNA or RNA).
BoysTable 1 - Footnote *
  • 1 urethral swab, premoistened in sterile water for meatal specimen; intraurethral specimen not recommended
  • Gram stain for gonococcal urethritis should be taken
  • Molecular diagnostic tests, especially NAATsTable 1 - Footnote *, are more sensitive than culture for C. trachomatis and N. gonorrhoeae
  • Cultures have been the preferred method for medico-legal purposes, but NAATs may be acceptable if positive results are confirmed by a second set of primers or, in some cases, a second test sent to another laboratory
  • If available, both tests (culture and NAAT) should be taken
  • If available, wet mount and/or culture for T. vaginalis should be taken
    Since culture tests collected <48 hours after exposure may be falsely negative, they should be repeated 1–2 weeks after exposure if prophylaxis is not offered; a postexposure NAAT can be taken at the time of presentation without waiting for 48 hours; this is based on expert opinion, which assumes that NAATs are able to detect inoculum (DNA or RNA).
  • 1 swab
  • N. gonorrhoeae culture should be taken
  • Test for C. trachomatis by culture if available; note that organisms can be detected in oropharynx from perinatal transmission for up to 6 months following birth
  • No approved NAAT for throat specimens
  • 1–2 swabs
  • N. gonorrhoeae and C. trachomatis culture should be taken; no approved NAATs at present
  • HSV culture should be taken (if inflammation present)
Genital ulcers
  • 1 swab
  • HSV culture should be taken
  • Direct or indirect fluorescent antibody (DFA/IFA) or NAAT (e.g., PCR) test should be taken for Treponema pallidum (see Syphilis chapter for details)
Serologic specimens Syphilis
  • Consider screening test(s) for syphilisTable 1 - Footnote
  • Syphilis tests should be repeated at 12 and 24 weeks after exposure. In some instances (e.g., high-risk assailant; see the Syphilis chapter) and in areas experiencing outbreaks of syphilis, it may be appropriate to repeat tests 2–4 weeks post-assault
Hepatitis B
  • If the child is known to be immune to hepatitis B (HBsAb ≥10 IU/L) or HBsAg-positive, then no testing is required
  • Baseline antibodies to HBsAg should be collected when hepatitis B immune status is unknown
  • Baseline HIV antibody testing should be collected
  • HIV antibody testing should be repeated at 6, 12 and 24 weeks following significant exposures
Hepatitis C
  • Baseline HCV antibody is optional, since transmission of HCV is low via sexual contact. It may be considered if the (alleged) perpetrator(s) is/are at high risk for hepatitis C (e.g., known injection drug user[s]) and significant trauma has occurred with the assault
  • If baseline testing has been performed and is negative, HCV antibody testing should be repeated at 12 and 24 weeks following significant exposures
Table 2. Implications of a diagnosis of STIs for a diagnosis of sexual abuseFootnote 2,Footnote 9
Incubation period of infection Probability of abuse Mother-to-child transmission
herpes simplex virus
human papillomavirus
Gonorrhea: 2–7 days Strong; probable if child >1 year Can be seen in children from 0–6 months of age
Chlamydia: 1–3 weeks, but up to 6 weeks Probable; strong if child >3 years Can be seen in children up to 3 years of age
HSV: 2–14 days Probable Can be seen in children up to 3 months of age
Trichomoniasis: 1–4 weeks Strong if child >6 months Can be seen in children 0–6 months of age
HPV: ≥1 month Possible; probable if >2 years Can be seen in children from 0–2 years of age
Syphilis: up to 90 days Strong Must be excluded
HIV: up to 6 months, but the majority seroconvert within 4–12 weeks Possible Must be excluded
Hepatitis B: up to 3 months Possible Must be excluded

Management and Treatment

Considerations for prophylaxis
  • Offer prophylaxis if:
  • It should be noted that the efficacy of antibiotic prophylaxis has not been studied in sexual assault; prophylaxis should be as recommended for treatment of specific infections. See chapters on specific infections for more information.
Table 3. Recommended prophylaxis for uncomplicated urogenital infections
See chapters on specific infections for alternate treatment choices and non-genital infections
Sexually transmitted infection Recommended prophylaxis
Table 3 - Footnote *
Cefixime should not be given to persons with cephalosporin allergy or a history of immediate and/or anaphylactic reactions to penicillins.
Table 3 - Footnote
Treatment for gonorrhea should be accompanied by treatment for chlamydia unless a NAAT is negative for chlamydia.
hepatitis B immune globulin
postexposure prophylaxis
  • ≤45 kg: azithromycin 15 mg/kg PO in a single dose (max 1 g) [A-l]
  • >45 kg: azithromycin 1 g PO in a single dose [A-l]
  • Treat only if positive for trichomonas
  • ≤45 kg: metronidazole 30 mg/kg/day PO divided every 6–12 hours for 1 week [B-lll]
  • >45 kg: metronidazole 2 g PO as a single doseFootnote 28 [A-l]
  • Prophylaxis with azithromycin (given for prophylaxis against chlamydia) is no longer considered to be effective against incubating syphilis in light of the recent emergence of syphilis resistant to azithromycin. Prophylaxis with other agents may be considered if the patient is unlikely to return or there is a potentially high-risk source in an area experiencing an outbreak of infectious syphilis (see Syphilis chapter for more information)
  • If the child subsequently has reactive syphilis serology, he/she should be retreated with a recommended treatment for syphilis
Hepatitis B
  • Prophylaxis for hepatitis B should be considered in all cases of sexual assault/abuse where the sexual acts have included anal or vaginal penetration or oral-anal contact without a condom, or if condom status is unknown and the source is not immune to hepatitis B (see Table 1). Oral-genital and oral-oral contact do not appear to be significant modes of transmissionFootnote 29
  • Recommended prophylaxis as outlined in the Canadian Immunization GuideFootnote 30 includes the following:
    • HBIG 0.06 mL/kg IM up to 14 days after exposure
    • A 3-dose course of hepatitis B vaccine at 0, 1 and 6 months following exposure or on an accelerated schedule
Hepatitis C
  • No PEP available
  • HIV PEP is recommended when the assailant is known to be HIV-infected and significant exposure has occurred (e.g., oral, anal and/or vaginal penetration without a condom or condom status unknown/broken)Footnote 31
  • PEP may also be available on a case-by-case basis for other high-risk exposures (e.g., source a known injection drug user, multiple assailants and/or significant injury) and vaginal, anal or oral penetration has occurred
  • Recommendations vary by province, and the decision to offer PEP should be made in conjunction with a pediatric HIV specialist
  • If HIV PEP is used, it should be started as soon as possible — no later than 72 hours after the assault — and continued for 28 daysFootnote 31
Other management issues
  • Appropriate referral should be made as necessary and available (e.g., to child protection authorities, sexual assault teams, local police/Royal Canadian Mounted Police, psychological support, local victim support organizations etc.).
  • Consideration should be given to assessing other children in the family or setting where the abuse is thought to have occurred, as it is not unusual to find other children who have also been sexually abused.Footnote 5
  • If the patient is sexually active, advise of the need to practice safer-sex or abstain from sexual intercourse until infection has been ruled out and/or prophylaxis is complete.
  • Offer tetanus toxoid if relevant (e.g., dirty wounds/abrasions sustained outdoors) and the child’s immunization schedule is not up to date.

Reporting and Partner Notification

  • Every province and territory has statutes in place that require the reporting of child abuse. Although the exact requirements may differ by province/territory, health care professionals should be aware of local reporting requirements and procedures with respect to child abuse and other acts of maltreatment. If reasonable cause to suspect child abuse exists, local child protection services and/or law enforcement agencies must be contacted promptly.
  • All persons named as suspects in child sexual abuse cases should be located and clinically evaluated; prophylactic treatment may or may not be offered and the decision to treat or not should be based on history, clinical findings and test results (See Sexual abuse in Peripubertal and Prepubertal Children chapter).
  • An individual with a confirmed notifiable STI should be reported to provincial/territorial authorities as appropriate.
  • Partner notification of individuals found to be infected with an STI should follow the recommendations in the relevant chapter.


  • Follow-up tests of cure are recommended for all curable STIs identified in peripubertal and prepubertal children. Follow-up will vary depending on the type of test performed and the type and duration of treatment given. In general, nucleic acid amplification tests should be repeated 3–4 weeks after completion of treatment and culture tests 4–5 days after completion of treatment.
  • If no prophylaxis was taken, follow-up should be arranged for 7–14 days after the original visit to review available laboratory test results and repeat an STI screen to detect infections acquired at the time of the assault that were not detected at the initial examination.
  • If empiric prophylactic therapy was given, follow-up should be arranged at 3–4 weeks.
  • Arrange follow-up serologic testing for HIV, hepatitis B and C, and syphilis as required (see Table 1).
  • Review mental state and arrange appropriate referral to mental health services if necessary.
  • Psychological and social support should also be offered to affected family members.


Footnote 1
Criminal Code of Canada, R.S. 1985 (Cwlth), c. C-46, s. 150(1)-153(1)
Footnote 2
American Academy of Pediatrics, Committee on Child Abuse and Neglect. Guidelines for the evaluation of sexual abuse of children: Subject review. Pediatrics 1999;103:186-191.
Footnote 3
Muram D. The medical evaluation of sexually abused children. Adolesc Pediatr Gynecol 2003;16:5-14.
Footnote 4
Finkelhor D. Sourcebook on Sexual Abuse. Beverly Hills (CA): Sage Productions;1986.
Footnote 5
Trocmé N, Maclaurin B, Fallon BB, et al. Canadian Incidence Study of Reported Child Abuse and Neglect : Final Report. Public Health Agency of Canada [online] 2001 [Cited 2006 Feburary 1]. Available at
Footnote 6
Hammerschlag, MR. The transmissibility of sexually transmitted diseases in sexually abused children. Child Abuse Negl 1998;22:623-635.
Footnote 7
Duncan ME, Tibaux G, Pelzer A, et al. First coitus before menarche and risk of sexually transmitted diseases. Lancet 1990;335:338-340.
Footnote 8
Greenberg J, Magder L, Aral S. Age at first coitus: A marker for risky sexual behavior in women. Sex Transm Dis 1992;19:331-334.
Footnote 9
Thomas A, Forster G, Robinson A, Rogstad A. National guideline for the management of suspected sexually transmitted infections in children and young people. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Disease). Sex Transm Infect 2002;78:324-331.
Footnote 10
Fallon MA, Eifler K, Niffenegger JP. Preventing and treating sexual abuse in children with disabilities: Use of a team model of intervention. J Paed Nurs 2002;17:363-367.
Footnote 11
Balogh R, Bretherton K, Whibley SS, et al. Sexual abuse in children and adolescents with intellectual disability. JIDR 2001;45(3):194-201.
Footnote 12
Andrews G, Gould B, Corry J. Child sexual abuse revisited. MJA 2002;176:458-459 .
Footnote 13
Jankowski MK, Leitenberg H, Henning K, Coffey P. Parental caring as a possible buffer against sexual revictimization in young adult survivors of child sexual abuse. J Trauma Stress 2002;15:235-244.
Footnote 14
Lee JK, Jackson HJ, Pattison P, Ward T. Developmental risk factors for sexual offending. Child Abuse Negl 2002;26:73-92.
Footnote 15
Bentovim A. Preventing sexually abused young people from becoming abusers, and treating the victimization experiences of young people who offend sexually. Child Abuse Negl 2002;26:661-678.
Footnote 16
Krugman RD. Recognition of sexual abuse in children. Pediatr Rev 1986;8:25-30
Footnote 17
Adams JA, Harper K, Knudson S, Revilla J. Examination findings in legally confirmed child sexual abuse: It’s normal to be normal. Pediatrics 1994;94:310-317.
Footnote 18
Johnson CF. Child sexual abuse. Lancet 2004;364:462-470.
Footnote 19
Friedrich WN, Grambsch P. Child sexual behaviour inventory: Normative and clinical. Psychol Assess 1992;4:303-311.
Footnote 20
Alberta Medical Association. Protocol for the Medical Examination of the Abused Child. Alberta Medical Association;1998.
Footnote 21
Faller KC. Child Sexual Abuse: Intervention and Treatment Issues. Department of Health and Human Services [online]. Washington (DC) 1993 [Cited 2006 February 1]. Available at:
Footnote 22
Centres for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2002. MMWR Recomm Rep 2002;51(RR-6):1-78.
Footnote 23
Adams J, Alderman E, Konop R, et al. Genital complaints in prepubertal girls [online]. 2004 [Cited 2005 February 1]. Available at :
Footnote 24
Black CM, Dreibe EM, Howard LA, Fajman NN et al. Multicenter study of nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrheae in children being evaluated for sexual abuse. Pediatr Infect Dis J 2009;7:608-13.
Footnote 25
Pokorny SF, Stormer J. Atraumatic removal of secretions from the prepubertal vagina. Am J Obstet Gynecol 1987;156:581-582.
Footnote 26
Embree JE, Lindsay D, Williams T, Peeling RW, Wood S, Morris M. Acceptability and usefulness of vaginal washes in premanarchal girls as a diagnostic procedure for sexually transmitted diseases. Pediatr Infect Dis J 1996;15:662-667.
Footnote 27
Bays J, Chadwick D. The serologic test for syphilis in sexually abused children. Adolesc Pediatr Gynecol 1991;4:148-151.
Footnote 28
Forna F, Gulmezoglu AM. Interventions for treating trichomoniasis in women. Cochrane Database Syst Rev 2000;3;CD000218.
Footnote 29
Schreeder MT, Thompson SE, Hadler SC, et al. Hepatitis B in homosexual men: Prevalence of infection and factors related to transmission. J Infect Dis 1982;146:7-15.
Footnote 30
Canadian Immunization Guide, 7th ed. Ottawa, ON: Public Health Agency of Canada; 2006.
Footnote 31
Smith DK, Grohskopf LA, Black RJ, et al. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: Recommendations from the U.S. Department of Health and Human Services. U.S. Department of Health and Human Services: MMWR Recomm Rep 2005;54(RR-2):1-20.

[Previous page] [Table of Contents] [Next page]